Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic disease
3.2.1.2 Increasing demand for personalized medicine
3.2.1.3 Growing advancement in organ-on-chip technology
3.2.1.4 Expanding use of organ-on-chip models in biomedical applications
3.2.2 Industry pitfalls & challenges
3.2.2.1 Challenges and intricacies in implementing organ-on-chip techniques
3.2.2.2 Regulatory obstacles
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Product
5.2.1 Liver-on-chip
5.2.2 Lung-on-chip
5.2.3 Heart-on-chip
5.2.4 Kidney-on-chip
5.2.5 Other products
5.3 Service
Chapter 6 Market Estimates and Forecast, By Material, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Polydimethylsiloxane (PDMS)
6.3 Polymer
6.4 Glass
Chapter 7 Market Estimates and Forecast, By Model Type, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Single-organ model
7.3 Multi-organ model
Chapter 8 Organ on Chip Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Drug discovery
8.3 Toxicity testing
8.4 Disease modeling
8.5 Personalized medicine
8.6 Other applications
Chapter 9 Market Estimates and Forecast, By End-User, 2018 – 2032 (USD Million)
9.1 Key trends
9.2 Pharmaceutical and biotechnology companies
9.3 Academic and research institutes
9.4 Other end-users
Chapter 10 Organ on Chip Market Estimates and Forecast, By Region, 2018 – 2032 (USD Million)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Altis Biosystems
11.2 AlveoliX AG
11.3 Axosim
11.4 Bi/ond Solutions B.V
11.5 Cherry Biotech
11.6 CN-Bio
11.7 Emulate, Inc.
11.8 Hesperos, Inc.
11.9 Insphero
11.10 MesoBioTech
11.11 Mimetas B.V.
11.12 Nortis Inc.
11.13 React4Life
11.14 TARA Biosystems (Valo Health)
11.15 TissUse GmbH
